XML 19 R5.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Distributions in Excess of Accumulated Net Income
Distributions in Excess of Accumulated Net Income
Cumulative Effect, Period of Adoption, Adjustment
Distributions in Excess of Accumulated Net Income
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Comprehensive (Loss) Income
Accumulated Comprehensive (Loss) Income
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Comprehensive (Loss) Income
Cumulative Effect, Period of Adoption, Adjusted Balance
Balance beginning of period (in shares) at Dec. 31, 2017       774,293,197 774,293,197                
Balance beginning of period at Dec. 31, 2017 $ 1,905,722   $ 1,918,478 $ 773 $ 773 $ 5,681,912 $ 5,681,912 $ (3,778,908)   $ (3,765,877) $ 1,945   $ 1,670
Balance beginning of period (ASU 2016-01) at Dec. 31, 2017   $ 0             $ 275     $ (275)  
Balance beginning of period (ASU 2017-05) at Dec. 31, 2017 [1]   $ 12,756             $ 12,756        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net (loss) income 83,849             83,849          
  Unrealized (loss) gain on derivatives 923                   923    
Reclassification to interest expense, net (956)                   (956)    
Distributions declared (53,782)             (53,782)          
Stock-based compensation, net (in shares)       825,081                  
Stock-based compensation, net 2,293     $ 1   2,292              
Repurchase of common stock under share repurchase plan (in shares)       (46,559,289)                  
Repurchase of common stock under share repurchase plan (98,491)     $ (45)   (98,446)              
Balance end of period (in shares) at Dec. 31, 2018       728,558,989                  
Balance end of period at Dec. 31, 2018 1,852,314     $ 729   5,585,758   (3,735,810)     1,637    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net (loss) income 38,399             38,399          
  Unrealized (loss) gain on derivatives 816                   816    
Reclassification to interest expense, net (1,396)                   (1,396)    
Distributions declared (53,473)             (53,473)          
Stock-based compensation, net (in shares)       766,500                  
Stock-based compensation, net 3,325     $ 1   3,324              
Repurchase of common stock under share repurchase plan (in shares)       (8,517,605)                  
Repurchase of common stock under share repurchase plan (20,384)     $ (9)   (20,375)              
Balance end of period (in shares) at Dec. 31, 2019       720,807,884                  
Balance end of period at Dec. 31, 2019 1,819,601     $ 721   5,568,707   (3,750,884)     1,057    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net (loss) income (10,174)             (10,174)          
  Unrealized (loss) gain on derivatives (16,199)                   (16,199)    
Reclassification to interest expense, net 2,634                   2,634    
Distributions declared (54,604)             (54,604)          
Reclassification to equity in losses of unconsolidated entities 59                   59    
Stock-based compensation, net (in shares)       711,981                  
Stock-based compensation, net 2,840         2,840              
Repurchase of common stock under share repurchase plan (in shares)       (2,136,119)                  
Repurchase of common stock under share repurchase plan (5,201)     $ (2)   (5,199)              
Common stock issuance costs in excess of proceeds from distribution reinvestment plan (in shares)       79,040                  
Common stock issuance costs in excess of proceeds from distribution reinvestment plan (93)         (93)              
Balance end of period (in shares) at Dec. 31, 2020       719,462,786                  
Balance end of period at Dec. 31, 2020 $ 1,738,863     $ 719   $ 5,566,255   $ (3,815,662)     $ (12,449)    
[1] See Note 6. Investments in Unconsolidated Entities.